Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
03/2004
03/11/2004US20040048828 Immunosuppressive agent and food
03/11/2004US20040048798 Especially CTL polypeptides of specific sequences
03/11/2004US20040048338 IL-17 receptor like molecules and uses thereof
03/11/2004US20040048237 Mammalian prion proteins and transgenic mice expressing them
03/11/2004US20040045511 Keeping case and partition plate for the same
03/11/2004CA2497263A1 Chromosomal loci for the stringent control of gene activities via transcription activation systems
03/11/2004CA2496904A1 Genetic suppression and replacement
03/11/2004CA2495207A1 Modified transferin-antibody fusion proteins
03/10/2004EP1395611A2 Methods and compositions for treating respiratory mucin production associated disease conditions
03/10/2004EP1395609A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
03/10/2004EP1395608A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/10/2004EP1395285A2 Reagents and methods for modulating dkk-mediated interactions
03/10/2004EP1395113A2 Use of follistatin to increase muscle mass
03/10/2004EP1395111A2 Cloning of transgenic animals comprising artificial chromosomes
03/10/2004EP1111991A4 Method of performing transgenesis
03/10/2004EP1105469A4 Mammalian transgenesis by intracytoplasmic sperm injection
03/10/2004CN1141391C Implantation method of sex-linked balance lethal and sex control gene for bombyx mori
03/09/2004US6703491 Nucleotide sequences; amino acid sequences; encoded proteins and derivatives/fragments; use of sequences in identifying genes modified by, or participating in signal transduction with fruit fly g-protein coupled receptor genes
03/09/2004US6703215 Detecting preferential enzyme inhibitor; obtain substrate, incubate with enzyme mixture, expose to enzyme inhibitor, monitor for decrease in enzymatic activity
03/09/2004CA1341451C Engraftment of immune-deficient mice with human cells
03/04/2004WO2004018680A1 Method of screening tumor antigen
03/04/2004WO2004018512A2 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications
03/04/2004WO2004017728A2 Methods
03/04/2004WO2004017727A1 A method of treatment and prophylaxis
03/04/2004WO2003097871A8 Marker molecules associated with lung tumors
03/04/2004WO2003055980A3 Il-17 like molecules and uses thereof
03/04/2004WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
03/04/2004WO2002078640A3 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
03/04/2004US20040045046 Transgenic mammals expressing polyglutamine
03/04/2004US20040045045 Animal model for toxicology and dose prediction
03/04/2004US20040045043 Comprises expression vectors for generating transgenic animal models for screening drugs and treating obesity and cardiovascular disorders
03/04/2004US20040045041 Means for the identification compounds capable of inhibiting karap-transduced signals
03/04/2004US20040043437 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
03/04/2004US20040043402 Interferon-alpha induced gene
03/04/2004CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis
03/03/2004EP1394542A1 Method of screening prion disease infection factor
03/03/2004EP1394274A2 Methods of testing for bronchial asthma or chronic obstructive pulmonary disease
03/03/2004EP1393624A1 Knockin nonhuman animal producing human tissue factor
03/03/2004EP1393623A1 Interstitial prostatism model animal
03/03/2004EP1393621A1 Keeping case and partition plate for the same
03/03/2004EP1393067A1 Encapsulated cell indicator system
03/03/2004EP1392859A2 Isolating cells expressing secreted proteins
03/03/2004EP1392845A2 A g-protein coupled receptor and uses therefor
03/03/2004EP1392828A2 Screens and assays for agents useful in controlling parasitic nematodes
03/03/2004EP1392725A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
03/03/2004EP1392345A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
03/03/2004EP1392112A2 Sca2 knockout animal and methods of use
03/03/2004EP1392111A1 Method for targeting transcriptionally active loci
03/03/2004EP1109571B1 Methods of treating salt-dependent hypertension
03/03/2004EP0647268B1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
03/03/2004CN1478387A Bamboo check cluster
03/03/2004CN1478386A Method of obtaining nutrients
03/03/2004CN1140172C Artificial insect ovum breader
03/02/2004US6701327 Merging network data sets comprising data acquired by interrogation of a network
03/02/2004US6700037 Genetically engineering swine embryos; culture swine embryos, translocate nucleus to another swine embryo, activate oocyte, monitor embryo development
03/02/2004US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder
03/02/2004US6699686 Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein
03/02/2004US6699468 Defective expression of the gamma 34.5 gene and the ribonucleotide reductase gene
03/02/2004US6699207 Method and apparatus for detecting lameness in animals
02/2004
02/26/2004WO2004016773A1 Transgenic cloned cow producing human prourokinase and method for producing the same
02/26/2004WO2004016751A2 Methods of treating neurodegenerative diseases
02/26/2004WO2004016742A2 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM
02/26/2004WO2004016732A2 Astrocyte modulated genes and uses thereof
02/26/2004WO2004016083A1 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy
02/26/2004WO2004016082A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide
02/26/2004WO2004016081A1 Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained
02/26/2004WO2004005548A3 A method for discovery of human genes associated with viral hepatitis infection
02/26/2004WO2003057846A3 Methods and materials for modulating task-3
02/26/2004WO2003039245A3 Transgenic mice knockout for histamine receptor h3 gene
02/26/2004WO2003038058A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
02/26/2004WO2003033669A3 Methods for screening and identifying host pathogen defense genes
02/26/2004WO2003029412A3 Restricted expression lentivial vectors
02/26/2004WO2002087321A3 Apparatus and method for mass production of insecticidal nematodes
02/26/2004WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
02/26/2004WO2002062204A3 Methods for diagnosing and treating heart disease
02/26/2004WO2002059263A3 Transgenic animals comprising a humanized immune system
02/26/2004WO2002057440A9 Screens and assays for agents useful in controlling parasitic nematodes
02/26/2004WO2002046382A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
02/26/2004US20040040052 Transgenic organism
02/26/2004US20040040051 Generation of non-human mammals by nuclear cloning
02/26/2004US20040040050 Combination of Nuclear Transfer (NT) and Embryonic Stem (ES) cell technologies that improves the efficiency of delilvering optimized genetically modified farm animals
02/26/2004US20040040048 Introducing atransgene into an embryo of the animal, which containing a nucleic acid encoding phytase, transplanting the embroy into a pseudopregnanat animal, allowing embryo to develop to term, detecting offspring expressing the transgene
02/26/2004US20040038896 For diagnosis and therapy
02/26/2004US20040038363 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
02/26/2004US20040038247 Expression vector comprised of regulatory sequences for lymphocyte specific expression of heterologous polypeptides
02/26/2004US20040038236 Mutation associated with epilepsy
02/26/2004US20040038226 Transgenic animal model by mineralocorticoid receptor antisense expression
02/26/2004US20040038209 Comprises nucleotide sequences coding beta -carotene dioxygenase which cleaves beta carotene and produces vitamin a aldehyde; improving nutritional value of plants, microorganisms and animal feeds
02/26/2004US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases
02/26/2004US20040037815 Isolation and use of solid tumor stem cells
02/26/2004CA2507486A1 .alpha.(1,3)-galactosyltransferase null cells, methods of selecting and .alpha.(1,3)-galactosyltransferase null swine produced therefrom
02/26/2004CA2495727A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide
02/26/2004CA2492927A1 Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained
02/25/2004EP1391516A1 Von willebrand factor (vwf)-cleaving enzyme
02/25/2004EP1391511A1 Artificial human chromosome containing human antibody lambda light chain gene
02/25/2004EP1391509A1 Transformed silkworm producing human collagen
02/25/2004EP1391508A1 Transgenic nematode expressing mammalian GPCRS used for screening assay
02/25/2004EP1391506A1 Animal with gene hypoexpression
02/25/2004EP1390896A2 Process for estimating random error in chemical and biological assays
02/25/2004EP1390744A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression